Bright Minds Biosciences ... (DRUG)

NASDAQ: DRUG · Real-Time Price · USD

32.68

-0.03 (-0.09%)

At close: Apr 28, 2025, 3:59 PM

31.00

-5.14%

Pre-market: Apr 29, 2025, 04:07 AM EDT

Bright Minds Biosciences Cash Flow Statement

Financials in CAD. Fiscal year is October - September.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019
Net Income	49.61K	-773.44K	229.9K	-574.14K	-1.68M	-1.53M	-1.46M	-2.05M	-2.34M	-2.96M	-2.66M	-4.49M	-4.86M	-2.87M	-3.53M	-1.5M	-753.42K	-402.62K	-29.62K	-16.73K	-31.41K
Depreciation & Amortization	21.53K	19.02K	18.11K	18.11K	18.11K	18.11K	18.11K	18.11K	18.11K	6.04K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	176.39K	210.24K	183.94K	226.64K	218.95K	400.5K	237.53K	29.96K	484.14K	29.91K	293.38K	290.83K	260.93K	376.56K	260.8K	6.84K	236.41K	161.3K	n/a	n/a	n/a
Other Working Capital	-101.76K	93.39K	-153.43K	28.22K	587.91K	-322.05K	-251.69K	458.67K	-934.05K	937.27K	-613.32K	570.92K	-122.92K	285.28K	48.39K	176.92K	18.21	-78.29	n/a	n/a	n/a
Other Non-Cash Items	-1.62M	-12.37K	-38.36K	775.37K	2.97K	3.79K	4.58K	2M	7.05K	-43.42K	4.28K	6.99K	-191.38K	-152.29K	293.25K	3.8K	-8.68	115.10	60.00	-31.68	-28.32
Deferred Income Tax	n/a	n/a	n/a	n/a	42.3K	163.44K	-130.47K	n/a	n/a	-6.04K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-118.56K	93.39K	-153.43K	-479.99K	579.85K	-255.36K	-322K	484.58K	-837.55K	845.93K	-501.36K	544.2K	-162.47K	253.12K	6.67K	140.67K	-94.37K	30.68K	49.42K	-21.1K	-28.32K
Operating Cash Flow	-1.49M	-463.17K	240.16K	-805.09K	-822.09K	-1.2M	-1.65M	484.58K	-2.66M	-2.13M	-2.86M	-3.65M	-4.95M	-2.39M	-2.97M	-1.35M	-611.37K	-210.63K	19.8K	-37.82K	-59.73K
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	22.88	-22.88	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-11.19M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	22.88	-22.88	n/a	n/a	n/a	n/a
Debt Repayment	-23.79K	-23.86K	-21.96K	-21.96K	-21.96K	-21.64K	-21.49K	-21.49K	-21.49K	24.84K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-9.7	n/a	n/a	n/a	n/a	-10	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	3.44M	302.00	n/a	n/a	n/a	n/a	n/a	n/a	1.06M	1M	12K	1.68K	118.25K	-9.7K	-545.55K	-1.2M	22.88K	n/a	n/a	n/a	60.00
Financial Cash Flow	52.04M	-23.56K	-21.96K	-21.96K	878.04K	-21.64K	-21.49K	-21.49K	2.25M	5.06M	12K	1.68K	118.25K	-9.7K	-545.55K	24.73M	1.88M	926.65K	-10K	91.68K	60.00
Net Cash Flow	52.18M	-470.15K	257.81K	-829.21K	13.66K	-1.38M	-1.54M	-10.73M	-416.41K	2.99M	-2.83M	-3.65M	-4.64M	-2.25M	-3.44M	23.39M	1.26M	716.02K	9.79K	53.86K	-59.73K
Free Cash Flow	-1.49M	-463.17K	240.16K	-805.09K	-822.09K	-1.2M	-1.65M	484.58K	-2.66M	-2.13M	-2.86M	-3.65M	-4.95M	-2.39M	-2.97M	-1.35M	-611.37K	-210.63K	19.8K	-37.82K	-59.73K